Oral contraceptives may increase risk for developing gliomas
the ONA take:
According to a new study published in the British Journal of Clinical Pharmacology, researchers have found that certain forms of birth control may increase the risk for developing a glioma, a rare brain cancer.
For the study, researchers analyzed data from Denmark's national registries of health records, cancer cases, and prescriptions in order to identify women aged 15 to 49 years diagnosed with glioma and which women were prescribed contraceptives.
Results showed that women who had used hormonal contraceptives (estrogen, progestin, or both) had a 50% increased risk for developing gliomas compared with those who did not take hormonal contraceptives. In addition, women who used birth control for greater than 5 years had a nearly 200% increased risk for developing gliomas.
Women taking progestin-only contraceptives were at a slightly higher risk for developing the brain cancer than those who took estrogen only or both. The researchers note that although the risk is doubled, the cancer is still rare. Specifically, among Danish women aged 15 to 49 years, only five in 100,000 will develop a glioma.
The results of the study were surprising as previous studies have found that estrogen and progestin may decrease the risk of gliomas, but particularly in post-menopausal women.
Certain forms of birth control may increase the risk for developing a glioma, a rare brain cancer.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|